Canada · Delayed Price · Currency is CAD Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CAD 289.55 billion. The enterprise value is 324.77 billion.
| Market Cap | 289.55B |
| Enterprise Value | 324.77B |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.77% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 12.94 and the forward PE ratio is 9.07.
| PE Ratio | 12.94 |
| Forward PE | 9.07 |
| PS Ratio | 3.34 |
| PB Ratio | 4.39 |
| P/TBV Ratio | 19.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 14.51 |
| EV / Sales | 3.72 |
| EV / EBITDA | 8.10 |
| EV / EBIT | 9.67 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 1.19 |
| Debt / FCF | n/a |
| Interest Coverage | 19.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 18.59% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.17M |
| Profits Per Employee | 302,371 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 3.74 billion in taxes.
| Income Tax | 3.74B |
| Effective Tax Rate | 14.32% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 18.37 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 50.60 |
| Average Volume (20 Days) | 9,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck & Co. had revenue of CAD 86.76 billion and earned 22.38 billion in profits. Earnings per share was 8.84.
| Revenue | 86.76B |
| Gross Profit | 67.14B |
| Operating Income | 33.40B |
| Pretax Income | 26.14B |
| Net Income | 22.38B |
| EBITDA | 39.37B |
| EBIT | 33.40B |
| Earnings Per Share (EPS) | 8.84 |
Balance Sheet
The company has 12.59 billion in cash and 47.52 billion in debt, giving a net cash position of -34.94 billion.
| Cash & Cash Equivalents | 12.59B |
| Total Debt | 47.52B |
| Net Cash | -34.94B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 66.01B |
| Book Value Per Share | 26.20 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 77.38%, with operating and profit margins of 38.49% and 25.79%.
| Gross Margin | 77.38% |
| Operating Margin | 38.49% |
| Pretax Margin | 30.12% |
| Profit Margin | 25.79% |
| EBITDA Margin | 45.37% |
| EBIT Margin | 38.49% |
| FCF Margin | n/a |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.77% |
| Shareholder Yield | n/a |
| Earnings Yield | 7.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |